Dna X (SONM) Total Non-Current Liabilities (2018 - 2026)

Dna X (SONM) has 9 years of Total Non-Current Liabilities data on file, last reported at $4.5 million in Q1 2026.

• Quarterly Total Non-Current Liabilities fell 87.17% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (down 87.17% YoY) and the FY2025 annual result came in at $50.5 million, up 15.35% from the prior year.
• Total Non-Current Liabilities eased to $4.5 million in Q1 2026, from $50.5 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $50.5 million in Q4 2025 to a low of $4.5 million in Q1 2026.
• A 5-year average of $31.0 million and a median of $32.1 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2025 — Total Non-Current Liabilities surged 68.02% — and 2026, when it slumped 87.17%.
• Tracing SONM's Total Non-Current Liabilities over 5 years: stood at $32.2 million in 2022, then retreated by 0.2% to $32.1 million in 2023, then jumped by 36.06% to $43.7 million in 2024, then advanced by 15.35% to $50.5 million in 2025, then plunged by 91.04% to $4.5 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $4.5 million (Q1 2026), $50.5 million (Q4 2025), and $39.1 million (Q3 2025), per Business Quant data.